Christopher Duma, MD, FACS

Christopher Duma, MD, FACS is the President and Founder of Regeneration Biomedical, Inc. (RBI), a clinical-stage company based in Newport Beach, California.12 Dr. Duma is a neurosurgeon with over 30 years of medical and research experience, specializing in the development and clinical application of stem cell therapies for neurodegenerative diseases.34

As a pioneer in his field, Dr. Duma has made significant contributions to the surgical and radiosurgical management of brain tumors, publishing numerous book chapters and journal articles on these topics.1 He is also an expert in minimally invasive neurosurgical procedures and holds an academic appointment at the University of California, Irvine.1

At Regeneration Biomedical, Dr. Duma leads the company's innovative approach to treating neurodegenerative diseases such as Alzheimer's, ALS, multiple sclerosis, Parkinson's disease, stroke, and traumatic brain injury.3 The company's proprietary therapy involves using Wnt-activated, autologous, adipose-derived stem cells (RB-ADSCs) administered directly into the lateral ventricles of the brain to bypass the blood-brain barrier.25

Dr. Duma has been instrumental in advancing RBI's research, including the recent initiation of a Phase 1 clinical trial for their stem cell therapy in Alzheimer's disease patients.26 He frequently presents the company's findings at scientific conferences and is actively involved in pushing the boundaries of regenerative medicine for neurological conditions.27